Product Images Argatroban

This appears to be a table or chart for monitoring the results of administering the anticoagulant drug Argatroban. The top row lists measurements for W aPTT (a blood clotting test) and the amounts of Argatroban in the patient's plasma at different times. The left column shows increasing infusion doses of the medication in terms of micrograms per kilogram of body weight per minute. However, the presence of non-English characters and unclear formatting makes it difficult to determine the full meaning or context of the information provided.*

This appears to be statistical data related to a study involving 160 subjects. 119% are marked as censored, and a p-value of 0.007 was obtained. The study is focused on "clinical endpoints," specifically death, amputation, and new thrombosis. The study was conducted over a 3 week period.*

This is a statistical report on a study, in which the historical control group included 46 subjects out of which 20 had censored results. The p-value for the study was calculated to be 0.018. The study was conducted over a period of up to 37 days, and "Censored" indicates that no clinical endpoint was observed during the follow-up period, which was defined as death, amputation, or new thrombosis.*

Argatroban is an injectable medication that comes in a single-dose vial containing 25mL. Each 2.5 mL of the solution contains 250 mg of Argatroban, and the vial is only available with a prescription. The solution also contains D-sorbitol and dehydrafed. The manufacturer is listed as "Bkt Gand Parma Liite," with the address given as Hyderabad 500043, India. The medication is intended for intravenous use and is manufactured for Hospira, Inc., located in Lake Forest, IL, USA.*

This is a medical label for Argatroban injection, which is administered intravenously. The injection comes in a single-dose vial that should be diluted prior to use. Each vial contains 250mg of Argatroban mixed with 2.5 mL of sterile solution. The usual adult dosage is not provided on this label, but the accompanying prescription information should be consulted. The injection should be protected from light before dilution and administered only by healthcare professionals. The manufacturer is Fopiaine and the product is distributed by ADEININDIA.*